Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
254 hedge funds and large institutions have $4.17B invested in Arena Pharmaceuticals Inc in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 84 increasing their positions, 97 reducing their positions, and 33 closing their positions.
55% more call options, than puts
Call options by funds: $32.5M | Put options by funds: $20.9M
12% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 33
6% more capital invested
Capital invested by funds: $3.94B → $4.17B (+$228M)
0% more funds holding
Funds holding: 253 → 254 (+1)
13% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 97
63% less funds holding in top 10
Funds holding in top 10: 8 → 3 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$154M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$81.7M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$46.5M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$33.1M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$98M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$48.9M |
| 3 |
HM
HealthCor Management
New York
|
-$43.2M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$42.4M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$41.9M |
ARNA Hedge Fund Activity: Q4 2020 in Review
254 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2020, worth a combined $4.17B — up 5.8% from $3.94B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new ARNA positions and 33 closed out — a net gain of 4 holders — while 84 added to existing stakes and 97 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $154M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $98M sold.
- 254 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2020, up from 253 in Q3 2020.
- Funds reported $4.17B of Arena Pharmaceuticals Inc stock for Q4 2020, up 5.8% quarter-over-quarter.
- 37 funds opened new Arena Pharmaceuticals Inc positions in Q4 2020 and 33 closed out, a net change of +4 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2020 was Wellington Management Group, an estimated $154M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2020 was Point72 Asset Management, an estimated $98M sold.
Based on aggregated 13F filings for Q4 2020.